Table 2.
Characteristics and level of asthma controla among children (aged 0–17 years) with current asthmab: Behavioral Risk Factor Surveillance System Asthma Call-back Survey, 2006–2010.
| Characteristics | Level of asthma control among children with current asthma | |||||||
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
| Controlled asthma | Uncontrolled asthma | |||||||
|
|
|
|||||||
| Survey respondents | Well-controlled asthma | Not-well-controlled | Very-poorly-controlled | |||||
|
|
|
|
|
|||||
| No.c | %d (95% CId) | No.c | %d (95% CId) | No.c | %d (95% CId) | No.c | %d (95% CId) | |
| Total | 9697 | 6144 | 61.6 (59.3–63.9) | 2065 | 21.5 (19.7–23.4) | 1453 | 16.9 (15.1–18.9) | |
| Sex | ||||||||
| Male | 5536 | 57.0 (54.7–59.3) | 3559 | 63.5 (60.5–66.4) | 1151 | 19.6 (17.3–22.0) | 826 | 16.9 (14.7–19.4) |
| Female | 4126 | 43.0 (40.7–45.4) | 2585 | 59.0 (55.4–62.5) | 914 | 24.1 (21.2–27.2) | 627 | 16.9 (14.1–20.2) |
| Age, year rangee | ||||||||
| 0–4 | 1213 | 18.3 (16.4–20.4) | 655 | 52.7 (46.7–58.8) | 265 | 21.4 (17.1–26.4) | 293 | 25.9 (21.2–31.2) |
| 5–11 | 3746 | 43.5 (41.2–45.9) | 2307 | 62.0 (58.6–65.3) | 835 | 22.0 (19.3–25.0) | 604 | 15.9 (13.6–18.6) |
| 12–17 | 4738 | 38.2 (36.0–40.4) | 3201 | 65.2 (61.6–68.7) | 975 | 20.8 (18.1–23.9) | 562 | 13.9 (11.0–17.4) |
| Race/ethnicitye,f | ||||||||
| White | 6472 | 57.2 (54.7–59.6) | 4218 | 62.9 (60.3–65.5) | 1354 | 21.4 (19.3–23.6) | 900 | 15.7 (13.8–17.9) |
| Black | 991 | 15.9 (14.2–17.9) | 537 | 53.7 (47.0–60.2) | 233 | 20.1 (16.3–24.5) | 221 | 26.3 (19.9–33.8) |
| Hispanic | 971 | 16.9 (15.0–19.1) | 591 | 59.0 (51.9–65.9) | 219 | 25.7 (19.7–32.8) | 161 | 15.3 (11.1–20.7) |
| Other race | 904 | 10.0 (8.5–11.6) | 597 | 69.3 (62.0–75.7) | 184 | 16.5 (12.4–21.7) | 123 | 14.2 (09.5–20.8) |
| Household incomee | ||||||||
| <$15 000 | 811 | 11.7 (9.9–13.9) | 420 | 49.2 (40.1–58.5) | 192 | 23.3 (16.3–32.1) | 199 | 27.5 (18.7–38.5) |
| $15 000–$24 999 | 1223 | 14.5 (12.9–16.3) | 707 | 59.0 (52.5–65.3) | 272 | 21.0 (16.3–26.6) | 244 | 20.0 (15.4–25.5) |
| $25 000–$49 999 | 2103 | 21.0 (19.3–22.9) | 1329 | 61.4 (56.9–65.7) | 445 | 19.9 (16.7–23.5) | 329 | 18.7 (15.5–22.4) |
| $50 000–$74 999 | 1684 | 16.6 (14.9–18.5) | 1107 | 69.1 (64.1–73.7) | 370 | 19.4 (15.8–23.7) | 207 | 11.5 (08.8–14.8) |
| ≥$75 000 | 3351 | 36.1 (34.0–38.3) | 2275 | 63.1 (59.5–66.6) | 676 | 22.4 (19.4–25.7) | 400 | 14.5 (12.1–17.3) |
| Health care coverage in past 12 months | ||||||||
| No insurance | 332 | 3.6 (2.9–4.4) | 203 | 62.0 (50.8–72.0) | 72 | 19.8 (12.7–29.6) | 57 | 18.2 (11.2–28.2) |
| Partial year coverage | 476 | 5.9 (4.4–7.8) | 257 | 55.8 (40.9–69.7) | 103 | 17.2 (11.2–25.6) | 116 | 27.0 (14.5–44.5) |
| Full year coverage | 8856 | 90.6 (88.6–92.2) | 5679 | 61.8 (59.5–64.1) | 1894 | 21.8 (20.0–23.9) | 1283 | 16.3 (14.6–18.1) |
| Cost as barriere, g | ||||||||
| Yes | 891 | 10.8 (9.3–12.4) | 404 | 46.3 (38.9–53.8) | 236 | 31.9 (24.5–40.5) | 251 | 21.8 (17.2–27.2) |
| No | 8746 | 89.2 (87.6–90.7) | 5711 | 63.3 (60.9–65.6) | 1830 | 20.3 (18.5–22.1) | 1205 | 16.5 (14.5–18.6) |
| Long-term control medicationse | ||||||||
| Yes | 4332 | 46.0 (43.7–48.3) | 2150 | 47.6 (44.2–51.0) | 1221 | 28.2 (25.4–31.3) | 961 | 24.2 (21.4–27.2) |
| No | 5365 | 54.0 (51.7–56.3) | 4013 | 73.5 (70.3–76.4) | 854 | 15.7 (13.5–18.1) | 498 | 10.8 (08.6–13.6) |
| Anyone smoked inside child's homeh | ||||||||
| Yes | 877 | 9.9 (8.3–11.8) | 527 | 57.3 (47.6–66.5) | 198 | 21.0 (15.6–27.6) | 152 | 21.7 (13.5–33.1) |
| No | 8796 | 90.1 (88.2–91.7) | 5615 | 62.0 (59.6–64.3) | 1875 | 21.6 (19.7–23.6) | 1306 | 16.5 (14.8–18.3) |
| If pets allowed in child's bedroom | ||||||||
| Pets allowed | 3754 | 33.3 (31.2–35.5) | 2518 | 66.9 (63.4–70.3) | 779 | 20.8 (18.0–23.8) | 457 | 12.3 (10.3–14.7) |
| Pets not allowed | 2226 | 22.7 (20.9–24.7) | 1345 | 59.8 (55.1–64.4) | 514 | 24.6 (20.5–29.3) | 367 | 15.5 (12.9–18.6) |
| No pets | 3710 | 44.0 (41.7–46.3) | 2295 | 58.4 (54.7–62.1) | 781 | 20.3 (17.7–23.2) | 634 | 21.3 (18.0–25.0) |
| Saw cockroach inside home past 30 d | ||||||||
| Yes | 721 | 8.0 (6.9–09.3) | 452 | 58.6 (50.6–66.2) | 148 | 23.3 (17.2–30.8) | 121 | 18.1 (13.1–24.5) |
| No | 8945 | 92.0 (90.7–93.1) | 5684 | 61.7 (59.3–64.1) | 1924 | 21.4 (19.5–23.3) | 1337 | 16.9 (15.0–19.0) |
| Saw or smelled mold past 30 d | ||||||||
| Yes | 929 | 9.1 (7.8–10.6) | 547 | 56.1 (47.8–64.1) | 235 | 30.4 (22.6–39.5) | 147 | 13.5 (09.6–18.7) |
| No | 8720 | 90.9 (89.4–92.2) | 5578 | 62.0 (59.6–64.4) | 1836 | 20.7 (18.9–22.6) | 1306 | 17.3 (15.4–19.4) |
CI, confidence interval.
Defined as the most impaired level from the 1 or more individual elements (i.e. daytime and night time symptoms in past 30 d and rescue medication use in past 3 months).
Persons who answered “yes” to the question “Have you ever been told by a doctor or other health professional that you had asthma?” or “Has a doctor.”
Unweighted pooled sample size, 2006–2010. Due to item non-response, individual characteristic categories may not sum to total.
Weighted prevalence and 95% confidence interval.
p Values <0.05 for the chi-square test of association between asthma controlled status and all selected variables.
Race categories “white, non-Hispanic”, “black, non-Hispanic”, include persons who indicated only a single race group. “Other races, non-Hispanic” includes Asian, American Indian Alaskan Native, Native Hawaiian and Other Pacific Islander, persons reporting more than one race, and persons reporting their race as something other than those listed here.
Cost as a barrier to primary care doctor, specialist, and medicine.
Indicates secondhand smoke exposure.